CatalystFDA/Bio

MERCK SAYS FDA APPROVED LABEL UPDATE FOR PAH THERAPY WINREVAIR - SEEKINGALPHA

FDA approval of a label update for Merck's Winrevair PAH therapy signals expanded use.

What changed

FDA approval of a label update for Merck's Winrevair PAH therapy signals expanded use.

Why it matters

FDA approval of a label update for Merck's Winrevair PAH therapy signals expanded use. — impact context not separately stored; see What changed.

Sources